Skip to content
Disclosery

Maple-Brown Abbott Ltd: D position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Maple-Brown Abbott Ltd on D, newest first. How the timeline and the estimate are built.

Maple-Brown Abbott Ltd held 1,652,333 D shares at 2025-03-31 per its 13F-HR filed 2025-05-13.

the latest 13F is the newest step

  1. period ended2025-03-31
    13F 1,652,333 shares
    Change vs previous 13F +491,713 shares

    6.32% of the 13F portfolio, value $92,653,745.

    13F-HR 0001681596-25-000005 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2024-12-31
    13F 1,160,620 shares
    Change vs previous 13F -19,830 shares

    7.62% of the 13F portfolio, value $62,510,993.

    13F-HR 0001681596-25-000002 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2024-09-30
    13F 1,180,450 shares
    Change vs previous 13F -70,180 shares

    6.77% of the 13F portfolio, value $68,218,205.

    13F-HR 0001681596-24-000016 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-06-30
    13F 1,250,630 shares
    Change vs previous 13F -43,070 shares

    6.46% of the 13F portfolio, value $61,280,870.

    13F-HR 0001681596-24-000006 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-03-31
    13F/A 1,293,700 shares
    Change vs previous 13F -42,360 shares

    6.51% of the 13F portfolio, value $63,637,104.

    13F-HR/A 0001681596-24-000012 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2023-12-31
    13F/A 1,336,060 shares
    Change vs previous 13F +160,410 shares

    6.4% of the 13F portfolio, value $62,794,820.

    13F-HR/A 0001681596-24-000010 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2023-09-30
    13F/A 1,175,650 shares
    Change vs previous 13F -23,280 shares

    6.02% of the 13F portfolio, value $52,516,285.

    13F-HR/A 0001681596-24-000009 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2023-06-30
    13F/A 1,198,930 shares
    Change vs previous 13F not available

    6.9% of the 13F portfolio, value $62,092,585.

    13F-HR/A 0001681596-24-000008 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).